alpha-aminopyridine has been researched along with Blood Poisoning in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 6 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anthony, S; Bajaj, A; Bhundia, V; Branson, A; Brookes, C; Darlison, L; Dawson, AG; Fennell, DA; Gaba, A; Greystoke, A; Hutka, M; King, A; Mohammed, S; Morgan, B; Nusrat, N; Poile, C; Richards, C; Scotland, M; Thomas, A; Wells-Jordan, P | 1 |
| Gong, X; Jia, J; Li, G; Wang, Q | 1 |
| Hu, B; Jiang, H; Liao, L; Tan, M; Xu, X | 1 |
| Chancharoenthana, W; Issara-Amphorn, J; Leelahavanichkul, A; Visitchanakun, P | 1 |
| Bayraktutan, Z; Bilen, A; Dincer, B; Halici, Z; Keskin, H; Kose, D; Sirin, B; Toktay, E | 1 |
| Gupta, K; Kumari, A; Pandey, S; Sen, P; Singh, G; Singh, R | 1 |
| Chen, J; Cheng, Y; Feng, H; Wang, H; Xu, J; Zhong, Q; Zou, Z | 1 |
| Chang, X; Hu, LF; Li, JB; Liu, XY; Ma, XJ; Yin, J | 1 |
| Colgan, SP; Eckle, T; Eltzschig, HK; Hartmann, K; Macmanus, CF; Schingnitz, U; Zug, S | 1 |
| Bryant, JW; Gibson, GW; Kolte, D; Shariat-Madar, Z; Wang, J | 1 |
1 trial(s) available for alpha-aminopyridine and Blood Poisoning
| Article | Year |
|---|---|
Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial.
Topics: Alanine Transaminase; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Diarrhea; Hemoptysis; Humans; Mesothelioma; Mesothelioma, Malignant; Pleural Neoplasms; Pulmonary Embolism; Respiratory Tract Infections; Sepsis; Thrombocytopenia; Vomiting | 2022 |
9 other study(ies) available for alpha-aminopyridine and Blood Poisoning
| Article | Year |
|---|---|
[Protective effect and mechanism of Ribociclib on sepsis induced-acute kidney injury].
Topics: Acute Kidney Injury; Aminopyridines; Animals; Male; Mice; Mice, Inbred C57BL; Protective Agents; Purines; Sepsis; Tumor Necrosis Factor-alpha | 2020 |
Roflumilast, a Phosphodiesterases-4 (PDE4) Inhibitor, Alleviates Sepsis‑induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Aminopyridines; Animals; Apoptosis; Benzamides; Blood Urea Nitrogen; Creatinine; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Cytokines; Female; Hepatitis A Virus Cellular Receptor 1; Inflammation; Kidney; Lipocalin-2; Mice; Mice, Inbred BALB C; NF-kappa B; Phosphodiesterase 4 Inhibitors; Sepsis | 2020 |
Syk Inhibitor Attenuates Polymicrobial Sepsis in FcgRIIb-Deficient Lupus Mouse Model, the Impact of Lupus Characteristics in Sepsis.
Topics: Aminopyridines; Animals; Cells, Cultured; Coinfection; Disease Models, Animal; Humans; Inflammation Mediators; Lipopolysaccharides; Lupus Erythematosus, Systemic; Lupus Nephritis; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Oxazines; Pyridines; Pyrimidines; Receptors, IgG; Sepsis; Signal Transduction; Syk Kinase | 2020 |
Roflumilast as a Potential Therapeutic Agent for Cecal Ligation and Puncture-Induced Septic Lung Injury.
Topics: Aminopyridines; Animals; Benzamides; Cecum; Cyclopropanes; Disease Models, Animal; Ligation; Lung; Lung Injury; NF-kappa B; Punctures; Rats; Sepsis | 2022 |
Roflumilast improves resolution of sepsis-induced acute kidney injury by retarding late phase renal interstitial immune cells infiltration and leakage in urinary sediments.
Topics: Acute Kidney Injury; Aminopyridines; Animals; Benzamides; Cyclopropanes; Disease Models, Animal; Kidney; Rats; Sepsis | 2022 |
Roflumilast reverses polymicrobial sepsis-induced liver damage by inhibiting inflammation in mice.
Topics: Aminopyridines; Animals; Anti-Inflammatory Agents; Bacterial Load; Benzamides; Cyclopropanes; Cytokines; Inflammation; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Sepsis; STAT3 Transcription Factor; Survival Analysis | 2017 |
Influence of roflumilast on sepsis mice through the JAK/STAT signaling pathway.
Topics: Aminopyridines; Animals; Anti-Inflammatory Agents; Benzamides; Bronchoalveolar Lavage Fluid; Cyclopropanes; Disease Models, Animal; Female; Janus Kinases; Lung; Male; Mice; Phosphodiesterase 4 Inhibitors; Sepsis; Signal Transduction; STAT3 Transcription Factor | 2019 |
Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury.
Topics: Acetamides; Acute Lung Injury; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Administration, Inhalation; Aminopyridines; Animals; Bone Marrow Transplantation; Cell Line; Cell Line, Tumor; Disease Models, Animal; Humans; Inflammation Mediators; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Purines; Receptor, Adenosine A2B; Sepsis; Signal Transduction | 2010 |
PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis.
Topics: Aminobenzoates; Aminopyridines; Animals; Blood Coagulation; Disease Models, Animal; Disseminated Intravascular Coagulation; Dose-Response Relationship, Drug; Inflammation Mediators; Lipopolysaccharides; Male; Plasma Kallikrein; Rabbits; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Sepsis; Thrombosis | 2012 |